The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects
Open accessAbstract
Background: Serotonin and its type‐4 (5‐hydroxytryptamine 4 ) receptor play a major role in the physiology of the gastrointestinal tract. The effect of intravenous and/or oral tegaserod, a 5‐hydroxytryptamine 4 receptor partial agonist, on gastric emptying, small bowel transit and colonic transit has not been studied in detail in humans. Aim: To assess the pharmacodynamic effects of repeated oral and intravenous administration of tegaserod on gastric emptying and small intestine and colonic transit. Methods: A randomized, placebo‐controlled, double‐blind, three‐way, crossover study of 6 mg oral and 0.6 mg intravenous tegaserod in 12 healthy male subjects was performed. Each treatment arm of the study involved 3 days of twice‐daily administration and 1 day of daily administration of the study drugs. Results: In comparison with placebo, oral and intravenous tegaserod significantly increased the gastric emptying rate ( P < 0.01), accelerated colonic filling ( P < 0.01) and shortened colonic transit at 48 h ( P < 0.05). Tegaserod shortened the small intestine transit time by 30% after oral and by 37% after intravenous administration. Conclusions: In healthy subjects, tegaserod markedly accelerated gastric emptying and small intestinal transit, and induced a small but significant acceleration of colonic transit. Tegaserod can act as a promotile agent throughout the gastrointestinal tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prather, C. M., Camilleri, M., Zinsmeister, A. R., McKinzie, S., & Thomforde, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70251-4 · Cited by 410
Cited by
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Parkman, H. P., Hasler, W. L., & Fisher, R. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.055 · Cited by 738
Pathophysiology and treatment of functional dyspepsia
Tack, J., Bisschops, R., & Sarnelli, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.030 · Cited by 518
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
Abell, T. L., Bernstein, V. K., Cutts, T., Farrugia, G., Forster, J., Hasler, W. L., Mccallum, R. W., Olden, K. W., Parkman, H. P., Parrish, C. R., et al. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00760.x · Cited by 361
Metadata
- Authors
- Degen, L., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H., & Beglinger, C.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2001-11-06
- Volume
- 15
- Issue
- 11
- Pages
- 1745-1751
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2023618163
- Cited by
- 211
- References
- 1
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. https://app.cochat.ai/papers/10.1046/j.1365-2036.2001.01103.x
- The paper
- Degen, L., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maecke, H., & Beglinger, C. (2001). Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2001.01103.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.